Evidence map›Paper›PMID 31170156›Full record

ArticlePLoS genetics2019

Asymmetrical localization of Nup107-160 subcomplex components within the nuclear pore complex in fission yeast.

Haruhiko Asakawa, Tomoko Kojidani, Hui-Ju Yang, Chizuru Ohtsuki, Hiroko Osakada, Atsushi Matsuda, Masaaki Iwamoto, Yuji Chikashige, Koji Nagao, Chikashi Obuse and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Structure and Function of the Nuclear Pore Complex.Cold Spring Harbor perspectives in biology · 2022
    Review
  10. Function of Nuclear Pore Complexes in Regulation of Plant Defense Signaling.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Review
  13. Evolution and diversification of the nuclear pore complex.Biochemical Society transactions · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Breaking the Y.PLoS genetics · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Haruhiko AsakawaGraduate School of Frontier Biosciences, Osaka University, Suita, Japan.ORCID 0000-0001-9675-658X
Tomoko KojidaniAdvanced ICT Research Institute Kobe, National Institute of Information and Communications Technology, Kobe, Japan.
Hui-Ju YangGraduate School of Frontier Biosciences, Osaka University, Suita, Japan.
Chizuru OhtsukiGraduate School of Frontier Biosciences, Osaka University, Suita, Japan.
Hiroko OsakadaAdvanced ICT Research Institute Kobe, National Institute of Information and Communications Technology, Kobe, Japan.
Atsushi MatsudaAdvanced ICT Research Institute Kobe, National Institute of Information and Communications Technology, Kobe, Japan.
Masaaki IwamotoAdvanced ICT Research Institute Kobe, National Institute of Information and Communications Technology, Kobe, Japan.ORCID 0000-0002-6284-3850
Yuji ChikashigeAdvanced ICT Research Institute Kobe, National Institute of Information and Communications Technology, Kobe, Japan.
Koji NagaoGraduate School of Life Science, Hokkaido University, Sapporo, Japan.ORCID 0000-0003-1418-6988
Chikashi ObuseGraduate School of Life Science, Hokkaido University, Sapporo, Japan.
Yasushi HiraokaGraduate School of Frontier Biosciences, Osaka University, Suita, Japan.
Tokuko HaraguchiGraduate School of Frontier Biosciences, Osaka University, Suita, Japan.ORCID 0000-0002-3813-6785
National Institute of Information and Communications Technology · JPThe University of Osaka · JPHokkaido University · JPJapan Women's University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nuclear pore complex (NPC) forms a gateway for nucleocytoplasmic transport. The outer ring protein complex of the NPC (the Nup107-160 subcomplex in humans) is a key component for building the NPC. Nup107-160 subcomplexes are believed to be symmetrically localized on the nuclear and cytoplasmic sides of the NPC. However, in S. pombe immunoelectron and fluorescence microscopic analyses revealed that the homologous components of the human Nup107-160 subcomplex had an asymmetrical localization: constituent proteins spNup132 and spNup107 were present only on the nuclear side (designated the spNup132 subcomplex), while spNup131, spNup120, spNup85, spNup96, spNup37, spEly5 and spSeh1 were localized only on the cytoplasmic side (designated the spNup120 subcomplex), suggesting the complex was split into two pieces at the interface between spNup96 and spNup107. This contrasts with the symmetrical localization reported in other organisms. Fusion of spNup96 (cytoplasmic localization) with spNup107 (nuclear localization) caused cytoplasmic relocalization of spNup107. In this strain, half of the spNup132 proteins, which interact with spNup107, changed their localization to the cytoplasmic side of the NPC, leading to defects in mitotic and meiotic progression similar to an spNup132 deletion strain. These observations suggest the asymmetrical localization of the outer ring spNup132 and spNup120 subcomplexes of the NPC is necessary for normal cell cycle progression in fission yeast.

Indexed as

Active Transport, Cell NucleusCell CycleCell DivisionCell NucleusCytoplasmHumansMeiosisMicroscopy, FluorescenceNuclear EnvelopeNuclear PoreNuclear Pore Complex ProteinsProtein BindingSaccharomyces cerevisiaeSchizosaccharomycesSchizosaccharomyces pombe ProteinsNuclear Pore Complex Proteinsnup107 protein, S pombeNup120 protein, S pombeNup132 protein, S pombeSchizosaccharomyces pombe Proteins

Identifiers

PMID31170156
PMCPMC6553703
OpenAlexW2949106801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.